Evidence map›Paper›PMID 20107840›Full record

ArticleHuman genetics2010

Kalirin: a novel genetic risk factor for ischemic stroke.

Tiago Krug, Helena Manso, Liliana Gouveia, João Sobral, Joana M Xavier, Isabel Albergaria, Gisela Gaspar, Manuel Correia, Miguel Viana-Baptista, Rita Moiron Simões and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Human genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 56 citations in OpenAlex.

  1. TTC7B emerges as a novel risk factor for ischemic stroke through the convergence of several genome-wide approaches.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2012
    Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Association between Serum Kalirin Levels and theThe journal of Tehran Heart Center · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Genetic Variant ofBioMed research international · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 1 country.

Tiago KrugInstituto Gulbenkian de Ciência, Oeiras, Portugal.
Helena Manso
Liliana Gouveia
João Sobral
Joana M Xavier
Isabel Albergaria
Gisela Gaspar
Manuel Correia
Miguel Viana-Baptista
Rita Moiron Simões
Amélia Nogueira Pinto
Ricardo Taipa
Carla Ferreira
João Ramalho Fontes
Mário Rui Silva
João Paulo Gabriel
Ilda Matos
Gabriela Lopes
José M Ferro
Astrid M Vicente
Sofia A Oliveira
Instituto Gulbenkian de Ciência · PTHospital de Santo António · PTNational Institute of Health Dr. Ricardo Jorge · PTHospital de Santa Maria · PTHospital de São Marcos · PTHospital Prof. Dr. Fernando Fonseca · PTHospital de Egas Moniz · PTHospital Garcia de Orta · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebrovascular and cardiovascular diseases are the leading causes of death and disability worldwide. They are complex disorders resulting from the interplay of genetic and environmental factors, and may share several susceptibility genes. Several recent studies have implicated variants of the Kalirin (KALRN) gene with susceptibility to cardiovascular and metabolic phenotypes, but no studies have yet been performed in stroke patients. KALRN is involved, among others, in the inhibition of inducible nitric oxide synthase, in the regulation of ischemic signal transduction, and in neuronal morphogenesis, plasticity, and stability. The goal of the present study was to determine whether SNPs in the KALRN region on 3q13, which includes the Ropporin gene (ROPN1), predispose to ischemic stroke (IS) in a cohort of Portuguese patients and controls. We genotyped 34 tagging SNPs in the KALRN and ROPN1 chromosomal region on 565 IS patients and 517 unrelated controls, and performed genotype imputation for 405 markers on chromosome 3. We tested the single-marker association of these SNPs with IS. One SNP (rs4499545) in the ROPN1-KALRN intergenic region and two SNPs in KALRN (rs17286604 and rs11712619) showed significant (P < 0.05) allelic and genotypic (unadjusted and adjusted for hypertension, diabetes, and ever smoking) association with IS risk. Thirty-two imputed SNPs also showed an association at P < 0.05, and actual genotyping of three of these polymorphisms (rs7620580, rs6438833, and rs11712039) validated their association. Furthermore, rs11712039 was associated with IS (0.001 < P < 0.01) in a recent well-powered genomewide association study (Ikram et al. 2009). These studies suggest that variants in the KALRN gene region constitute risk factors for stroke and that KALRN may represent a common risk factor for vascular diseases.

Indexed as

Polymorphism, Single NucleotideAdultAgedAge of OnsetBrain IschemiaFemaleGuanine Nucleotide Exchange FactorsHumansLinkage DisequilibriumMaleMembrane ProteinsMiddle AgedProtein Serine-Threonine Kinasesrho GTP-Binding ProteinsRisk AssessmentRisk FactorsGuanine Nucleotide Exchange FactorsKALRN protein, humanMembrane ProteinsProtein Serine-Threonine Kinasesrho GTP-Binding ProteinsROPN1 protein, human

Identifiers

PMID20107840
OpenAlexW2164954658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.